The Harmony Non-Invasive Prenatal Test provides screening for the risk of chromosomal abnormalities. In as early as 10 weeks, women of all ages* are able to know whether or not their child is at high risk, and all it takes is a single blood draw.
*Both under 35 and over 35 age groups, studies have included women ages 18-48
References: 1. Norton et al. N Engl J Med. 2015 Apr 23;372(17):1589-97.
The Harmony Prenatal Test measures a woman’s risk of carrying a baby with chromosomal conditions such as Trisomies 21, 18 and 13. If your test indicates a high risk result, talk with your healthcare provider about what further diagnostic testing is needed to confirm the result. The Harmony Prenatal Test was developed by Ariosa Diagnostics, a laboratory certified by the federal government to perform highly complex tests. This test is a lab–developed test and has not been reviewed or approved by the FDA.
The Harmony Prenatal Test was developed by Ariosa Diagnostics, a CLIA-certified laboratory. As with other lab-developed tests, it has not been cleared or approved by the FDA and is not available for sale as an IVD in the US. Non-invasive prenatal testing (NIPT) based on cell-free DNA analysis is not diagnostic; results should be confirmed by diagnostic testing.